Abstract
The MT3 antigen is defined serologically as a DR supertypic specificity and is strongly associated with DR4, DR7, and DRw9. To determine whether the MT3 molecule is distinct from the DR molecule, DR4 and MT3 antigens were immunoprecipitated from 125I-labeled plasma membrane glycoproteins of a DR4-homozygous, MT3-homozygous B lymphoid cell line, Wa, and compared by two-dimensional (2-D) gel electrophoresis. The precipitates with two different anti-DR4 alloantisera and with three different mouse antibodies against human Ia monomorphic determinants gave the same 2-D gel pattern consisting of one heavy chain with a molecular weight of 34 000 and a set of light chains with a molecular weight of 30000, indicating that these polypeptides are the components of the DR4 molecule. On the other hand, all three anti-MT3 alloantisera used precipitated an identical set of anti-MT3 alloantisera specific light chains with a molecular weight of 30 000, and one heavy chain with a molecular weight of 34 000. The pl of the MT3 light chain was more acidic than that of the DR4 light chain. The amount of MT3 light chains was much smaller than that of DR4 light chains in unlabeled plasma membrane glycoproteins. Thus, we have demonstrated directly using 2-D gel electrophoresis and anti-MT3 alloantisera that the MT3 antigen is a new human Ia molecule distinct from DR4.
Similar content being viewed by others
References
Allison, J. P., Walker, L. E., Rusell, W. A., Pellegrino, M. A., Ferrone, S., Reisfeld, R. A., Frelinger, J. A., and Silver, J.: Murine Ia and human DR antigens: Homology of amino-terminal sequences. Proc. Natl. Acad. Sci. U.S.A. 75: 3959–3956, 1978
Andrews, D. W., Bono, M. R., and Strominger, J. L.: A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing. Biochemistry 21: 6625–6628, 1982
Auffray, C., Korman, A. J., Roux-Dosseto, M., Bono, R., and Strominger, J. L.: cDNA clone for the heavy chain of the human B cell alloantigen DC1: Strong sequence homology to the HLA-DR heavy chain. Proc. Natl. Acad. Sci. U.S.A. 79: 6337–6341, 1982
De Kretser, T. A., Crumpton, M. J., Bodmer, J. G., and Bodmer, W. F.: Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DRI, 2, w6 monoclonal antibody: Evidence for a third locus. Eur. J. Immunol. 12: 600–606, 1982
Delovich, T. L. and Falk, J. A.: Evidence for structural homology between murine and human Ia antigens. Immunogenetics 8: 405–418, 1979
Duquesnoy, R. J. and Marrai, M.: Joint report; MB system. In P. J. Terasaki (ed.): Histocompatibility Testing 1980, pp. 552–555, UCLA 1981
Goyert, S. M., Shively, J. E., and Silver, J.: Biochemical characterization of human Ia molecules. HLADS, equivalent to murine I-A subregion molecules. J. Exp. Med. 156: 550–566, 1982
Hurley, C. K., Shaw, S., Nadler, S. S., and Cappa, J. D.: Alpha and beta chains of SB and DR antigens are structurally distinct. J. Exp. Med. 156: 1557–1562, 1982
Jones, P. P.: Analysis of radiolabeled lymphocyte proteins by one- and two-dimensional polyacrylamide gel electrophoresis. In B. B. Mishell and S. M. Shigi (eds.): Selected Methods in Cellular Immunology, pp. 398–440, W. H. Freeman and Company, San Francisco, 1980
Juji, T., Maeda, H., and Omori, K.: Joint Report; MT2. In P. J. Terasaki (ed.): Histocompatibility Testing 1980, pp. 565–566, UCLA, 1981
Karr, R. W., Kannapell, C. C., Stein, J. A., Gebel, H. M., Mann, D. L., Duquesnoy, R. J., Fuller, T. C., Rodey, G. E., and Schwartz, B. D.: Molecular relationships of the human B cell alloantigens, MT2. MB3, MT4, and DR5. J. Immunol. 128: 1809–1818, 1982a
Karr, R. W., Kannapell, C. C., Stein, J. A., Fuller, T. C., Duquesnoy, R. L., Rodey, G. E., Mann, D. L., Gebel, H. M., and Schwartz, B. D.: Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J. Exp. Med. 156: 652–657, 1982b
Katagiri, M., Ikeda, H., Maruyama, N., Moriuchi, J., Wakisaka, A., Kimura, S., Aizawa, M., and Itakura, K.: Evidence for two B-cell alloantigen loci in the HLA-D region. Immunogenetics 9: 335–351, 1979
Koyama, K., Nakamuro, K., Tanigaki, N., and Pressman, D.: Alloantigens of human lymphoid cell lines; ‘Human la-like antigens’: Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology 33: 217–230, 1977
Lampson, L. A. and Levy, R.: Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125: 229–293. 1980
Markert, M. L. and Cresswell, P.: Human B cell alloantigens: Expression of MB and MT determinants. J. Immunol. 128: 2004–2008, 1982
Molnar, J., Markovic, G., Chao, H., and Molnar, Z.: Glycoproteins of Ehrlich ascites carcinoma cells: Separation of plasma and endoplasmic reticular membrane fragments. Arch. Biochem. Biophys. 134: 524–532, 1969
Owen, M. J., Kissonerghis, A. M., Lodish, H. F., and Crumpton, M. J.: Biosynthesis and maturation of HLA-DR antigens in vivo. J. Biol. Chem. 256: 8987–8993, 1981
Reinherz, E. L., Kung, P. C., Pesando, J. M., Ritz, J., Goldstein, G., and Schlossman, S. F.: Ia determinants on human T-cell subsets defined by monoclonal antibody. J. Exp. Med. 150: 1472–1482, 1979
Shackelford, D. A. and Strominger, J. L.: Demonstration of structural polymorphism among HLA-DR light chains by two-dimensional gel electrophoresis. J. Exp. Med. 151: 144–165, 1980
Shackelford, D. A., Mann, D. L., van Rood, J. J., Ferrara, G. B., and Strominger, J. L.: Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc. Natl. Acad. Sci. U.S.A. 78: 4566–4570. 1981
Shaw, S., Kavathas, P., Pollack, M. S., Charmot, D., and Mawas, C.: Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO. Nature 293: 745–747, 1981
Tanigaki, N., Tosi, R., Pressman, D., and Ferrara, G. B.: Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics 10: 151–167, 1980
Terasaki, P. I.: Joint Report: Histocompatibility Testing 1980, pp. 506–545, UCLA, 1981
Tosi, R., and Tanigaki, N.: Joint Report: MT1. In P. J. Terasaki (ed.): Histocompatibility Testing 1980, pp. 558–562, UCLA, 1981
Tosi, R.: Joint Report: MT3. In P. J. Terasaki (ed.): Histocompatibility Testing 1980, p. 568, UCLA, 1981
Uhr, J. W., Capra, J. D., Vitetta, E. S., and Cook, R. G.: Organization of the immune response genes. Science 206: 292–298, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, M., Maeda, H., Mukai, R. et al. Identification of the MT3 molecule using two-dimensional gel electrophoresis and alloantisera. Immunogenetics 18, 575–583 (1983). https://doi.org/10.1007/BF00345965
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00345965